Nektar Therapeutics
NKTR
#5687
Rank
C$1.59 B
Marketcap
C$78.61
Share price
-1.37%
Change (1 day)
266.42%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.29 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are C$0.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.34 B-1.51%
2023-12-31C$0.35 B-24.11%
2022-12-31C$0.46 B-16.32%
2021-12-31C$0.55 B-5.2%
2020-12-31C$0.58 B-21.23%
2019-12-31C$0.74 B26.77%
2018-12-31C$0.58 B11.32%
2017-12-31C$0.52 B-18.06%
2016-12-31C$0.64 B-5.38%
2015-12-31C$0.68 B45.17%
2014-12-31C$0.47 B-15.75%
2013-12-31C$0.55 B24.54%
2012-12-31C$0.44 B7.81%
2011-12-31C$0.41 B-3.4%
2010-12-31C$0.43 B-13.55%
2009-12-31C$0.49 B10.55%
2008-12-31C$0.45 B-11.6%
2007-12-31C$0.50 B-19.14%
2006-12-31C$0.63 B1.77%
2005-12-31C$0.61 B85.69%
2004-12-31C$0.33 B-43.21%
2003-12-31C$0.58 B-7.04%
2002-12-31C$0.63 B-0.12%
2001-12-31C$0.63 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
C$111.24 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$159.74 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$107.25 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
C$56.22 M-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$94.61 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
C$19.13 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$0.82 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
C$156.85 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA